Clinical Trial Update: Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial comparing candesartan–amlodipine combination therapy to candesartan alone in hypertensive patients not adequately controlled on candesartan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• candesartan monotherapy (candesartan)
• candesartan-amlodipine combination therapy

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Hypertension | Phase 3 | Status: COMPLETED